Cited by 551Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer and biochemical research

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells

Open access

Israelsen, William J., Dayton, Talya L., Davidson, Shawn M., Fiske, Brian P., Hosios, Aaron M., Bellinger, Gary, Li, Jie, Yu, Yimin, Sasaki, Mika, Horner, James W., Burga, Laura N., Xie, Jianxin, Jurczak, Michael J., DePinho, Ronald A., Clish, Clary B., Jacks, Tyler, Kibbey, Richard G., Wulf, Gerburg M., Di Vizio, Dolores, Mills, Gordon B., Cantley, Lewis C., Vander Heiden, Matthew G.·2013·Cell

DOI 10.1016/j.cell.2013.09.025PMC PMC3850755

Open this paper in CoChat — free account Open PDF

Abstract

The pyruvate kinase M2 isoform (PKM2) is expressed in cancer and plays a role in regulating anabolic metabolism. To determine whether PKM2 is required for tumor formation or growth, we generated mice with a conditional allele that abolishes PKM2 expression without disrupting PKM1 expression. PKM2 deletion accelerated mammary tumor formation in a Brca1-loss-driven model of breast cancer. PKM2 null tumors displayed heterogeneous PKM1 expression, with PKM1 found in nonproliferating tumor cells and no detectable pyruvate kinase expression in proliferating cells. This suggests that PKM2 is not necessary for tumor cell proliferation and implies that the inactive state of PKM2 is associated with the proliferating cell population within tumors, whereas nonproliferating tumor cells require active pyruvate kinase. Consistent with these findings, variable PKM2 expression and heterozygous PKM2 mutations are found in human tumors. These data suggest that regulation of PKM2 activity supports the different metabolic requirements of proliferating and nonproliferating tumor cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2013.09.025

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citation
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Untitled work
(1989) · PubMed · Cited by 3,343
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Self-citation
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683
Self-citation
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., et al. (2011) · Science · doi:10.1126/science.1211485 · Cited by 1,218

Flagged first, then by citations

Show all 48 references

Sorted by citations

Items 201–300 of 551

Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
Chhipa, A. S., & Patel, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119694 · Cited by 44
Pyruvate Kinase M2 Regulates Apoptosis of Intestinal Epithelial Cells in Crohn’s Disease
Tang, Q., Ji, Q., Xia, W., Li, L., Bai, J., Ni, R., & Qin, Y. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3189-0 · Cited by 44
Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging
Yao, F., Zhang, C., Du, W., Liu, C., & Xu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138213 · Cited by 44
Targeting metabolic pathways for head and neck cancers therapeutics
Yamamoto, M., Inohara, H., & Nakagawa, T. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9691-z · Cited by 44
The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose
Li, X., Deng, S., Liu, M., Jin, Y., Zhu, S., Deng, S.-J., Chen, J., He, C., Qin, Q., Wang, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0158-5 · Cited by 44
The expression and role of glycolysis-associated molecules in infantile hemangioma
Chen, J., Wu, D., Dong, Z., Chen, A., & Liu, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118215 · Cited by 44
The Genomes of Two Billfishes Provide Insights into the Evolution of Endothermy in Teleosts
Wu, B., Feng, C., Zhu, C., Xu, W., Yuan, Y., Hu, M., Yuan, K., Li, Y., Ren, Y., Zhou, Y., et al. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab035 · Cited by 43
Differential Mobility Spectrometry: A Valuable Technology for Analyzing Challenging Biological Samples
Campbell, J. L., Blanc, J. Y. L., & Kibbey, R. G. (2015) · Bioanalysis · doi:10.4155/bio.15.14 · Cited by 43
Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma
Sanders, E. B., & Diehl, S. (2015) · Oncoscience · doi:10.18632/oncoscience.128 · Cited by 43
Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells
Yu, L., Teoh, S. T., Ensink, E., Ogrodzinski, M. P., Yang, C., Vazquez, A. I., & Lunt, S. Y. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0205-z · Cited by 44
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
Sun, W., Ge, Y., Cui, J., Yu, Y., & Liu, B. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.03.010 · Cited by 42
lncRNA HITT Inhibits Lactate Production by Repressing PKM2 Oligomerization to Reduce Tumor Growth and Macrophage Polarization
Zhao, K., Wang, X., Zhao, D. H., Lin, Q., Zhang, Y., & Hu, Y. (2022) · Research · doi:10.34133/2022/9854904 · Cited by 43
The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer
Seyfried, T. N., Lee, D. C., Duraj, T., Ta, N. L., Mukherjee, P., Kiebish, M. A., Arismendi-Morillo, G., & Chinopoulos, C. (2025) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-025-10059-w · Cited by 45
IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer
Wen, Y., Liu, W., Sun, H., Ge, X. Q., Shi, Z., Wang, M., Li, W., Zhang, J., Liu, L.-Z., & Jiang, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-15607-y · Cited by 42
Positron emission tomography reporter gene strategy for use in the central nervous system
Haywood, T., Beinat, C., Gowrishankar, G., Patel, C. B., Alam, I. S., Murty, S., & Gambhir, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901645116 · Cited by 42
Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis
Wubben, T. J., Pawar, M. D., Weh, E., Smith, A. J. H., Sajjakulnukit, P., Zhang, L., Dai, L., Hager, H. M., Pai, M. P., Lyssiotis, C. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59999-w · Cited by 42
CARM1 suppresses de novo serine synthesis by promoting PKM2 activity
Abeywardana, T., Oh, M., Jiang, L., Yang, Y., Song, J., Song, J., & Yang, Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004512 · Cited by 42
PKM2 promotes reductive glutamine metabolism
Miao, L., Yuanyuan, W., Yuxia, R., Changsen, B., Li, Q., Yanfen, C., Guoguang, Y., & Binghui, L. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0122 · Cited by 42
Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
Lei, P., Wang, W., Sheldon, M., Sun, Y., Yao, F., & Ma, L. (2023) · Cancers · doi:10.3390/cancers15133390 · Cited by 45
Glucose metabolism is inhibited by caspases upon the induction of apoptosis
La, P., Villa, E., Zunino, B., Marchetti, S., & Ricci, J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.371 · Cited by 41
Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics
Qian, Y. (2014) · World Journal of Translational Medicine · doi:10.5528/wjtm.v3.i2.37 · Cited by 41
Nuclear localization of metabolic enzymes in immunity and metastasis
He, Y., Gao, M., Cao, Y., Tang, H., Liu, S., & Tao, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.002 · Cited by 40
Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells
Almouhanna, F., Blagojevic, B., Can, S., Ghanem, A., & Wölfl, S. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00239-8 · Cited by 40
Succinyl-5-aminoimidazole-4-carboxamide-1-ribose 5′-Phosphate (SAICAR) Activates Pyruvate Kinase Isoform M2 (PKM2) in Its Dimeric Form
Yan, M., Chakravarthy, S., Tokuda, J. M., Pollack, L., Bowman, G. D., & Lee, Y. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00658 · Cited by 39
Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2
Tanaka, F., Yoshimoto, S., Okamura, K., Ikebe, T., & Hashimoto, S. (2018) · Oncotarget · doi:10.18632/oncotarget.25850 · Cited by 38
Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism
Luo, Q., Liang, W., Zhang, Z., Zhu, Z., Chen, Z., Hu, J., Yang, K., Chi, Q., & Ding, G. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155245 · Cited by 40
Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation
Veras, F. P., Públio, G. A., de Melo, B. M. S., Prado, D. D. S., Norbiato, T., Cecílio, N. T., Hiroki, C. H., Damasceno, L. E. A., Jung, R., Toller-Kawahisa, J. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111897 · Cited by 38
RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring
Zhang, Y., Gao, Y., Wang, Y., Jiang, Y., Yan, X. Y., Wang, X., Wang, Z., Ding, Y., Chen, H., Rui, B., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01212-3 · Cited by 38
Glycolytic genes in cancer cells are more than glucose metabolic regulators
Hu, Z.-Y., Xiao, L., Bode, A. M., Dong, Z., & Cao, Y. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1174-x · Cited by 38
Molecular determinants as therapeutic targets in cancer chemotherapy: An update
Haider, T., Tiwari, R., Vyas, S. P., & Soni, V. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.011 · Cited by 38
An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer
Dastmalchi, N., Safaralizadeh, R., Baradaran, B., Hosseinpourfeizi, M., & Baghbanzadeh, A. (2019) · Gene · doi:10.1016/j.gene.2019.144301 · Cited by 38
Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report
Seyfried, T. N., Shivane, A. G., Kalamian, M., Maroon, J. C., Mukherjee, P., & Zuccoli, G. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.682243 · Cited by 37
LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells
Yang, J., Bennett, B. D., Luo, S. J., Inoue, K., Grimm, S. A., Schroth, G. P., Bushel, P. R., Kinyamu, H. K., & Archer, T. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00426-15 · Cited by 38
Targeting Energy Metabolism in Cancer Treatment
Kubik, J., Humeniuk, E., Adamczuk, G., Madej, B., & Korga-Plewko, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105572 · Cited by 39
Physiology of PNS axons relies on glycolytic metabolism in myelinating Schwann cells
Deck, M., van Hameren, G., Campbell, G. R., Bernard‐Marissal, N., Devaux, J. J., Berthelot, J., Lattard, A., Médard, J., Gautier, B., Guelfi, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272097 · Cited by 39
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 44
SUMOylation disassembles the tetrameric pyruvate kinase M2 to block myeloid differentiation of leukemia cells
Li, X., Jiang, Y., Zhang, X., Wang, X., Wei, R., Qin, K., & Lu, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03400-9 · Cited by 37
Pyruvate kinase M2 in chronic inflammations: a potpourri of crucial protein–protein interactions
Patel, S., Das, A., Meshram, P., Sharma, A., Chowdhury, A., Jariyal, H., Datta, A., Sarmah, D., Nalla, L. V., Sahu, B., et al. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09605-0 · Cited by 37
A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells
Li, X., Wang, X., Wang, X., Liu, S.-H., Ding, X., Chen, G., & Lu, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737056 · Cited by 36
Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment
Rihan, M., Nalla, L. V., Dharavath, A., Shard, A., Kalia, K., & Khairnar, A. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00226-0 · Cited by 39
Metabolic Reprogramming in Cancer: Role of HPV 16 Variants
Arizmendi-Izazaga, A., Navarro‐Tito, N., Jiménez‐Wences, H., Catalán, M. A. M., Martínez-Carrillo, D. N., Zacapala-Gómez, A. E., Olea‐Flores, M., Dircio-Maldonado, R., Torres‐Rojas, F. I., Soto-Flores, D. G., et al. (2021) · Pathogens · doi:10.3390/pathogens10030347 · Cited by 37
Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment
Garg, C., Khan, H., Kaur, A., Singh, T. G., Sharma, V., & Singh, S. K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106194 · Cited by 39
Dual roles of β-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer
Yu, H., Wang, M., Zhang, T., Cao, L., Li, Z., Du, Y., Hai, Y., Gao, X., Ji, J., & Wu, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123231119 · Cited by 36
Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells
Miao, Y., Lü, M., Yan, Q., Li, S., & Feng, Y.-J. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14685034103671 · Cited by 36
Retracted
Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses
Walls, J. F., Subleski, J. J., Palmieri, E. M., Gonzalez-Cotto, M., Gardiner, C. M., McVicar, D. W., & Finlay, D. K. (2020) · eLife · doi:10.7554/elife.59166 · Cited by 35
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
Tuerhong, A., Xu, J., Shi, S., Tan, Z., Meng, Q., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03866-y · Cited by 35
Sucrose, fructose, glucose, and their link to metabolic syndrome and cancer
Das, U. N. (2014) · Nutrition · doi:10.1016/j.nut.2014.05.015 · Cited by 35
PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells
Mukherjee, J., Ohba, S., See, W. L., Phillips, J. J., Molinaro, A. M., & Pieper, R. O. (2016) · International Journal of Cancer · doi:10.1002/ijc.30041 · Cited by 36
Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders
Serpa, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_1 · Cited by 35
Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR
Wu, M., An, J., Zheng, Q., Xin, X., Lin, Z., Li, X., Li, H., & Lu, D. (2016) · Oncotarget · doi:10.18632/oncotarget.9089 · Cited by 34
PKM2 is not required for pancreatic ductal adenocarcinoma
Hillis, A. L., Lau, A. N., Devoe, C. X., Dayton, T. L., Danai, L. V., Vizio, D. D., & Heiden, M. G. V. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0188-1 · Cited by 34
Molecular Mediators of Metabolic Reprogramming in Cancer: Mechanisms, Regulatory Networks, and Therapeutic Strategies
Ahuja, S., & Zaheer, S. (2025) · Immunology · doi:10.1111/imm.70045 · Cited by 43
A critical review of the role of M2PYK in the Warburg effect
Harris, R. A., & Fenton, A. W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.004 · Cited by 32
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 32
An engineered photoswitchable mammalian pyruvate kinase
Gehrig, S. M., Macpherson, J. A., Driscoll, P. C., Symon, A., Martin, S. R., MacRae, J. I., Kleinjung, J., Fraternali, F., & Anastasiou, D. (2017) · FEBS Journal · doi:10.1111/febs.14175 · Cited by 33
Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
Kitayama, K., Yashiro, M., Morisaki, T., Miki, Y., Okuno, T., Kinoshita, H., Fukuoka, T., Kasashima, H., Masuda, G., Hasegawa, T., et al. (2017) · Cancer Science · doi:10.1111/cas.13421 · Cited by 32
Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions
Bi, Y.-H., Han, W., Li, R., Wang, Y., Du, Z., Wang, X.-J., & Jiang, Y. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i16.1936 · Cited by 33
Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma
Tech, K., Deshmukh, M., & Gershon, T. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.017 · Cited by 31
Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma
Dayton, T. L., Gocheva, V., Miller, K. M., Bhutkar, A. J., Lewis, C. A., Bronson, R. T., Heiden, M. G. V., & Jacks, T. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0179-2 · Cited by 34
Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
Matrka, M. C., Watanabe, M., Muraleedharan, R., Lambert, P. F., Lane, A. N., Romick‐Rosendale, L. E., & Wells, S. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177952 · Cited by 31
PKM2 activation sensitizes cancer cells to growth inhibition by 2-deoxy-D-glucose
Tee, S. S., Park, J. M., Hurd, R. E., Brimacombe, K. R., Boxer, M. B., Massoud, T. F., Rutt, B. K., & Spielman, D. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19630 · Cited by 34
Intestinal epithelial PKM2 serves as a safeguard against experimental colitis via activating β-catenin signaling
Sun, X., Yao, L., Liang, H., Wang, D., He, Y., Yao, W., Ye, L., Wang, K., Li, L., Chen, J., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0197-6 · Cited by 31
Cotton cytosolic pyruvate kinase GhPK6 participates in fast fiber elongation regulation in a ROS-mediated manner
Zhang, B., & Liu, J. (2016) · Planta · doi:10.1007/s00425-016-2557-8 · Cited by 30
Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill
Wang, G., Wang, Y.-Z., Yu, Y., & Wang, J. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.02.029 · Cited by 31
Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation
Chen, T., Wang, H., Liu, J.-S., Cheng, H.-H., Hsu, S.-C., Wu, M.-C., Lu, C., Wu, Y.-F., Wu, J.-W., Liu, Y.-Y., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0343-4 · Cited by 30
Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer
Yan, S., Hu, L.-M., Hao, X.-H., Liu, J., Tan, X., Geng, Z., Ma, J., & Wang, Z. (2022) · iScience · doi:10.1016/j.isci.2022.104773 · Cited by 30
Modeling metabolism: A window toward a comprehensive interpretation of networks in cancer
Reséndis-Antonio, O., González-Torres, C., Jaime-Muñoz, G., Hernandez-Patiño, C. E., & Salgado-Muñoz, C. F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.003 · Cited by 31
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
Chen, N., Zhou, Y.-S., Wang, L.-C., & Huang, J. (2022) · Oncology Reports · doi:10.3892/or.2022.8266 · Cited by 29
Molecular glues: enhanced protein-protein interactions and cell proteome editing
Weagel, E. G., Foulks, J. M., Siddiqui, A. Q., & Warner, S. L. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02882-2 · Cited by 31
High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
Zhao, Y., Shen, L., Chen, X., Qian, Y., Zhou, Q., Wang, Y. X., Li, K., Liu, M., Zhang, S., & Huang, X. (2015) · PubMed · doi:10.14670/hh-11-627 · Cited by 29
Lin28A induces energetic switching to glycolytic metabolism in human embryonic kidney cells
Docherty, C. K., Salt, I. P., & Mercer, J. R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0323-2 · Cited by 29
Metabolic regulation of T cell development by Sin1–mTORC2 is mediated by pyruvate kinase M2
Ouyang, X., Han, Y., Qu, G., Li, M., Wu, N., Liu, H., Arojo, O., Sun, H., Liu, X., Liu, D., et al. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy065 · Cited by 29
PKM2-mediated STAT3 phosphorylation promotes acute liver failure via regulating NLRP3-dependent pyroptosis
Yu, S., Pei, S., Zhang, M., Gao, S., Chen, J., Duan, L., Hu, E., Wang, Y., & Huang, Y. (2024) · Communications Biology · doi:10.1038/s42003-024-07227-w · Cited by 28
Targeting glycolysis: exploring a new frontier in glioblastoma therapy
Yang, L., Li, S., Yu, L., Leng, J., & Li, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1522392 · Cited by 28
Metabolic implication of tumor:stroma crosstalk in breast cancer
Morandi, A., & Chiarugi, P. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1124-7 · Cited by 29
PARP and other prospective targets for poisoning cancer cell metabolism
Michels, J., Obrist, F., Castedo, M., Vitale, I., & Kroemer, G. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.026 · Cited by 28
Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery
Lv, W., Liu, D., Liu, X.-C., Feng, T., Li, L., Qian, B., & Li, W. (2018) · BMC Cancer · doi:10.1186/s12885-018-5023-0 · Cited by 28
Triterpenoids Extracted fromRhus chinensis MillAct Against Colorectal Cancer by Inhibiting Enzymes in Glycolysis and Glutaminolysis: Network Analysis and Experimental Validation
Wang, G., Wang, Y.-Z., Yu, Y., Wang, J., Yin, P., & Xu, K. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1631858 · Cited by 28
Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors
Hsieh, I., Gopula, B., Chou, C., Wu, H.-Y., Chang, G., Wu, W., Chang, C., Chu, P., & Chen, C. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00763 · Cited by 28
PTBP1 is necessary for dendritic cells to regulate T‐cell homeostasis and antitumour immunity
Geng, G., Xu, Z., Peng, N., Li, Y., Liu, J., Wu, J., Liang, J., Zhu, Y., & Shi, L. (2021) · Immunology · doi:10.1111/imm.13304 · Cited by 28
The Pro-Apoptotic Role of the Regulatory Feedback Loop between miR-124 and PKM1/HNF4α in Colorectal Cancer Cells
Sun, Y., Zhao, X., Luo, M., Zhou, Y., Ren, W., Wu, K., Li, X., Shen, J., & Hu, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034318 · Cited by 28
Mitochondrial Changes in Cancer
Rao, S. G. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_40 · Cited by 30
Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer
Das, R., Pulugu, P., Singh, A. A., Chatterjee, D. R., Baviskar, S., Vyas, H., Behera, S. K., Srivastava, A., Kumar, H., & Shard, A. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01512 · Cited by 27
The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
Carvalho, T. M. A., Cardoso, H. J., Figueira, M. I., Vaz, C. V., & Socorro, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.053 · Cited by 27
circATP2B1 Promotes Aerobic Glycolysis in Gastric Cancer Cells Through Regulation of the miR-326 Gene Cluster
Zhao, X., Tian, Z., & Liu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628624 · Cited by 28
Defining the roles for Vpr in HIV-1-associated neuropathogenesis
James, T., Nonnemacher, M. R., Wigdahl, B. L., & Krebs, F. C. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0436-5 · Cited by 28
Cancer‐associated mutations in human pyruvate kinase M2 impair enzyme activity
Liu, V. M., Howell, A. J., Hosios, A. M., Li, Z., Israelsen, W. J., & Heiden, M. G. V. (2019) · FEBS Letters · doi:10.1002/1873-3468.13648 · Cited by 26
The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress
Masaki, S., Hashimoto, K., Kihara, D., Tsuzuki, C., Kataoka, N., & Suzuki, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.182 · Cited by 26
Loss of PKM2 in Lgr5+ intestinal stem cells promotes colitis-associated colorectal cancer
Kim, Y., Lee, Y., Kang, S. W., Kim, S., Kim, T., Lee, S.-H., Hwang, S. W., Kim, J., Kim, E. N., Ju, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42707-8 · Cited by 26
IgSF11-mediated phosphorylation of pyruvate kinase M2 regulates osteoclast differentiation and prevents pathological bone loss
Kim, H., Takegahara, N., & Choi, Y. (2023) · Bone Research · doi:10.1038/s41413-023-00251-2 · Cited by 22
Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma
Lockney, N. A., Zhang, M., Lu, Y., Sopha, S. C., Washington, M. K., Merchant, N. B., Zhao, Z., Shyr, Y., Chakravarthy, A. B., & Xia, F. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9764-6 · Cited by 25
NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma
Zhou, L., Ding, L., Gong, Y., Zhao, J., Zhang, J., Mao, Z., Wang, Z., Zhang, W., & Zhou, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.677763 · Cited by 24
Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas
Miro, C., Nappi, A., Cicatiello, A. G., Cicco, E. D., Sagliocchi, S., Murolo, M., Belli, V., Troiani, T., Albanese, S., Amiranda, S., et al. (2021) · Cancers · doi:10.3390/cancers13112743 · Cited by 26
Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path
Iessi, E., Vona, R., Cittadini, C., & Matarrese, P. (2021) · Biomedicines · doi:10.3390/biomedicines9121942 · Cited by 26
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma
Davidson, S. M., Heyman, J. E., O’Brien, J. P., Liu, A. C., Schmidt, D. R., Israelsen, W. J., Dayton, T. L., Sehgal, R., Bronson, R. T., Freinkman, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2352 · Cited by 24
Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession
Liu, Y., Song, D., Liang, D.-M., Li, Y., Yan, Y., Sun, H., Zhang, M., Hu, J., Zhao, Y.-L., Liang, Y., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01095-1 · Cited by 27
Metabolic switch in cancer – Survival of the fittest
Raskov, H., Gaggar, S., Tajik, A., Orhan, A., & Gögenür, I. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.025 · Cited by 26
Missense Mutations in Pyruvate Kinase M2 Promote Cancer Metabolism, Oxidative Endurance, Anchorage Independence, and Tumor Growth in a Dominant Negative Manner
Iqbal, M. A., Siddiqui, F. A., Chaman, N., Gupta, V., Kumar, B., Prakasam, G., & Bamezai, R. N. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515742 · Cited by 24
The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer
Zhu, W., Lü, M., Wang, X., Xu, Z., Gao, C., & Qin, L. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.016 · Cited by 25
From Glucose to Lactate and Transiting Intermediates Through Mitochondria, Bypassing Pyruvate Kinase: Considerations for Cells Exhibiting Dimeric PKM2 or Otherwise Inhibited Kinase Activity
Chinopoulos, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.543564 · Cited by 23

Authors: Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J. W., Burga, L. N., Xie, J., Jurczak, M. J., DePinho, R. A., Clish, C. B., Jacks, T., Kibbey, R. G., Wulf, G. M., Di Vizio, D., Mills, G. B., Cantley, L. C., & Vander Heiden, M. G.
Affiliations: Koch Institute for Integrative Cancer Research At MIT (US)
The University of Texas MD Anderson Cancer Center (US)
Beth Israel Deaconess Medical Center (US)
Dana-Farber Cancer Institute (US)
Cell Signaling Technology (United States) (US)
Yale University (US)
Broad Institute (US)
ORCID: Israelsen, William J.
Dayton, Talya L.
Davidson, Shawn M.
Fiske, Brian P.
Hosios, Aaron M.
Li, Jie
Yu, Yimin
Sasaki, Mika
Burga, Laura N.
Xie, Jianxin
Jurczak, Michael J.
DePinho, Ronald A.
Clish, Clary B.
Jacks, Tyler
Kibbey, Richard G.
Wulf, Gerburg M.
Mills, Gordon B.
Cantley, Lewis C.
Venue: Cell
Publisher: Elsevier BV
Published: 2013-10
Volume: 155
Issue: 2
Pages: 397-409
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2013.09.025
PMC: PMC3850755
OpenAlex: W1975215468
Cited by: 549
References: 48
Citations by year: 2026: 25 · 2025: 35 · 2024: 46 · 2023: 32 · 2022: 56 · 2021: 56 · 2020: 43 · 2019: 41 · 2018: 41 · 2017: 44 · 2016: 32 · 2015: 41 · 2014: 50 · 2013: 5
FWCI: 14.99
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 374 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
PMC
Funders: Damon Runyon Cancer Research Foundation
Richard and Susan Smith Family Foundation
Agios Pharmaceuticals
National Institutes of Health (DK059635)
National Cancer Institute (5-P30-CA14051, P50CA098258, K08CA136983, R01CA168653, R00CA131472, P30CA014051, P01CA117969, P30CA147882)
National Institute of General Medical Sciences (R01GM056203)
National Institute of Diabetes and Digestive and Kidney Diseases (U24DK059635, R01DK092606, DK059635)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords: PKM2, PKM1, tumor cell proliferation, mammary tumor formation, BRCA1, breast cancer, cancer metabolism, conditional knockout mice, tumor heterogeneity, anabolic metabolism
MeSH terms: Animals, Base Sequence, Breast Neoplasms, Exons, Female, Humans, Isoenzymes, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Models, Molecular, Molecular Sequence Data, Mutation, Neoplasm Metastasis, Neoplasm Transplantation, Pyruvate Kinase, RNA Splicing, Mutagenesis, Gene Deletion, Mice, Gene Knockout Techniques, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks